News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
123 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27813)
Month
January (4345)
February (4356)
March (4475)
April (4721)
May (4999)
June (4103)
July (3643)
August (3329)
September (4039)
October (5055)
November (4470)
December (3799)
Day
1 (243)
2 (71)
4 (13)
5 (208)
6 (218)
7 (196)
8 (217)
9 (66)
11 (10)
12 (147)
13 (179)
14 (161)
15 (149)
16 (59)
18 (5)
19 (123)
20 (157)
21 (145)
22 (146)
23 (65)
24 (1)
25 (5)
26 (148)
27 (167)
28 (180)
29 (149)
30 (99)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Job Trends
DaVita Announces Preliminary Results Of Self-Tender Offer
The total of 21,969,132 shares that the Company expects to accept for repurchase represents approximately 13.7% of the Company’s total outstanding shares of common stock as of August 16, 2019.
August 19, 2019
·
9 min read
Business
Check-Cap and GE Healthcare Announce Completion of Manufacturing Line Transfer Implementation and Qualification for the C-Scan® System Operated by GE Healthcare
GE Healthcare facility in Chicago to support clinical investigation needs of the C-Scan® System in the U.S.
August 19, 2019
·
4 min read
Policy
Possible Plan Launches With Call To Action To Fund And Empower Those Impacted By Cannabis Prohibition
Possible Plan Focuses on Equitable Access and Reparatory Justice Initiatives with The New York Times Magazine’s The 1619 Project Partnership
August 19, 2019
·
3 min read
Policy
Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag Disorder - Aug. 19, 2019
Vanda Pharmaceuticals Inc. announced that on August 16 2019, it received a Complete Response Letter from the U.S. Food and Drug Administration as part of its ongoing review of Vanda’s supplemental New Drug Application for HETLIOZ® for the treatment of Jet Lag Disorder.
August 19, 2019
·
4 min read
Oxford Finance LLC Provides $7.5M USD Term Loan to MolecuLight to Support Global Commercial Expansion
The financing will further support MolecuLight’s commercial expansion for the growing global demand for its MolecuLight i:X device.
August 19, 2019
·
3 min read
Deals
Aurora Cannabis Completes Hempco Food and Fibre Acquisition
Introduces Aurora Hemp: A Global Hemp Leader Focused on CBD and Organic Hemp Food Products
August 19, 2019
·
9 min read
Valens Begins Trading on the OTCQX Best Market in the U.S.
Diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab is pleased to announce the Company has qualified to trade on the OTCQX® Best Market in the U.S.
August 19, 2019
·
3 min read
Biotech Bay
Higher Cell Densities Spur Demand for New Cell Culture Fluid Harvesting & Clarification Approaches
Biopharmaceutical companies address H&C challenges by mapping end-to-end workflows and tightly defining success outcomes, finds Frost & Sullivan
August 19, 2019
·
3 min read
Business
Complexa Names Theodore Danoff, MD, PhD, Chief Medical Officer
Experienced industry leader to head Complexa’s clinical development programs
August 19, 2019
·
3 min read
BioMidwest
Eton Pharmaceuticals Announces Positive Results from Clinical Study Report of ET-104
ET-104 Successfully Demonstrated Bioequivalence to Currently Approved Oral Solid Formulation
August 19, 2019
·
3 min read
Previous
2 of 13
Next